Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Central Asia Tbk (BBCA) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

Bank Central Asia Tbk
Hetzer Medical Indonesia Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Bank Central Asia Tbk vs Hetzer Medical Indonesia Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,225 (market cap 753.61T, 180.06M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp80 (market cap 126.56B, 63.42M 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 5954.6× Hetzer Medical Indonesia Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (180.06M versus 63.42M). Which is the better fit depends on your goals.

BBCAMEDS
Market Cap
753.61T126.56B
Volume
180.06M63.42M
Lot
1.8M634.18K
Turnover
1.11T5.05B
Average Price
6,176.8979.59
Value
1.11T5.05B
Indicative Equilibrium Price
6,22580
Indicative Equilibrium Volume
292.85K16.96K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBCA
View details
MEDS
View details

About Bank Central Asia Tbk

PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.

Read more on BBCA

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS